Principals

Co-CEO and CFO

Howard M. Newburg, CPA

Co-CEO

John R. Garrett, PhD

CSO

John M. McCoy, PhD

Staff Scientists

Dr. Matt Heidtman
Dr. Massimo Merighi

Advisory Board

David S. Newburg, PhD (Chairman)
Boston College

Professor Muhammad Yunus
Grameen Bank

Ardythe L. Morrow, PhD
Cincinnati Children's Hospital Medical Center (CCHMC); University of Cincinnati

Guillermo M. Ruiz-Palacios, MD
Instituto Nacional de Ciencias Médicas y Nutrición, México; Universidad Nacional Autónoma de México

Phillips W. Robbins, PhD
Boston University Medical Center

John M. McCoy, PhD
Glycosyn LLC

Daniel M. Ratner, PhD
University of Washington

Board of Directors

Vidar J. Jorgensen
David S. Newburg, PhD
Howard M. Newburg, CPA (Chairman)
John R. Garrett, PhD

Legal Counsel

Business Counsel: John Chu, Chu, Ring and Hazel
Intellectual Property Counsel: Ingrid A. Beattie, PhD, Esq.
  • David S. Newburg, PhD

  • John M. McCoy, PhD

  • John R. Garrett, PhD

  • Vidar J. Jorgensen

  • Rocky Tsao, Esq

  • Ingrid Beattie, PhD, Esq.

  • John Chu

  • Matt Heidtman

  • Massimo Merighi

  • Guillermo M. Ruiz-Palacios, MD

    Dr. Guillermo M. Ruiz-Palacios, MD (National University of Mexico; Residency in Internal Medicine, National Institute of Nutrition, Mexico City; Fellowship in Infectious Disease, University of Texas Medical School–Houston) is Professor of Internal Medicine and Chair of the Department of Infectious Diseases of the National Institute of Medical Sciences and Nutrition in Mexico City. His department has more than 100 faculty, staff, and trainees. Dr. Ruiz-Palacios serves on the Scientific Advisory Committee of Glycosyn LLC He is recognized internationally for his research on infectious diarrhea and strategies for prevention and treatment and as such has been a member of a number of steering committees and working groups of the World Health Organization. He has more than 100 publications on infectious disease, has served as the President of the Infectious Disease Society of Mexico. Dr. Ruiz-Palacios is a Fellow of the Infectious Diseases Society of America and member of the American Society of Microbiology, the New York Academy of Sciences, and the Campylobacter Society. His research is funded by the U.S. National Institutes of Health, the government of Mexico, and private industry.